Veerhealth Care — 360° view

Veerhealth Care, a company in the Pharmaceuticals industry, reported revenue of ₹22 crore and net profit of ₹1.21 crore for the September 2026 quarter.

Veerhealth Care (BSE: VEERHEALTH) closed at ₹58.45 on 20 Nov 2026, up 229.7% over the past year. Its market capitalisation is ₹117 crore and it trades at 51.5 times earnings.

Share price
₹58.45 (20 Nov 2026)
Market cap
₹117 Cr (20 Nov 2026)
P/E
51.49 (20 Nov 2026)
Revenue
₹22 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
7.21% (FY26)
ROE
2.97% (FY26)
Book value
₹15.2 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹58.96 / ₹16.70 (20 Nov 2026)
1-year return
229.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: VEERHEALTH

Incorporated in 1992, Veer Healthcare Ltd is in the business of trading, manufacturing and marketing research based ayurvedic medicines

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.